These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23208715)

  • 41. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population.
    Prakash R; Gupta R; Katoch VM; Tiwari PK
    J Infect Public Health; 2017; 10(5):593-599. PubMed ID: 28245964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria.
    Gomez DI; Fisher-Hoch SP; Bordt AS; Quitugua TN; Robledo J; Alvarez N; Correa N; McCormick JB; Restrepo BI
    Diagn Microbiol Infect Dis; 2010 May; 67(1):37-46. PubMed ID: 20227226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
    Munir S; Mahmood N; Shahid S; Khan MI
    Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
    Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
    J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin.
    Horng YT; Jeng WY; Chen YY; Liu CH; Dou HY; Lee JJ; Chang KC; Chien CC; Soo PC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1542-8. PubMed ID: 25534743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR.
    Gonçalves MG; Fukasawa LO; Oliveira RS; Salgado MM; Harrison LH; Shutt KA; Sacchi CT
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):903-8. PubMed ID: 23147147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China.
    Huang H; Jin Q; Ma Y; Chen X; Zhuang Y
    Tuberculosis (Edinb); 2002; 82(2-3):79-83. PubMed ID: 12356458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon.
    Tekwu EM; Sidze LK; Assam JP; Tedom JC; Tchatchouang S; Makafe GG; Wetewale AL; Kuaban C; Eyangoh S; Ntoumi F; Beng VN; Frank M
    BMC Microbiol; 2014 May; 14():113. PubMed ID: 24884632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis.
    Bisson GP; Mehaffy C; Broeckling C; Prenni J; Rifat D; Lun DS; Burgos M; Weissman D; Karakousis PC; Dobos K
    J Bacteriol; 2012 Dec; 194(23):6441-52. PubMed ID: 23002228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex.
    Xu G; Liu H; Jia X; Wang X; Xu P
    Tuberculosis (Edinb); 2021 May; 128():102083. PubMed ID: 33975262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Zeng MC; Jia QJ; Tang LM
    J Int Med Res; 2021 Mar; 49(3):300060521997596. PubMed ID: 33715498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea.
    Cho EH; Bae HK; Kang SK; Lee EH
    Korean J Lab Med; 2009 Oct; 29(5):455-60. PubMed ID: 19893355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
    McCammon MT; Gillette JS; Thomas DP; Ramaswamy SV; Graviss EA; Kreiswirth BN; Vijg J; Quitugua TN
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2200-9. PubMed ID: 15917513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.